Abstract
Microbes are the most prevalent living organisms in the biosphere; they constitute about 50 % of the Earth’s weight. They are also the most prolific in terms of the production of antibiotics and other bioactive small molecules. This rich store of chemical diversity (termed the Parvome) provides an inexhaustible source of therapeutic agents that has barely been investigated. Devising new ways of harvesting these compounds is a major challenge that requires developing new insights into their origin and evolution and also predictions of their roles in chemical and biological evolution. Only with this information will it be possible to exploit their pharmaceutical potential to the full.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baltz RH (2010) Genomics and the ancient origins of the daptomycin biosynthetic gene cluster. J. Antibiot (Tokyo) 63:506–511
Banfield JF, Young M (2009) Variety- the Splice of Life- in Microbial Communities. Science 326:1198–1199
Bush K, Jacoby GA (2010) Updated functional classification of β-lactamases. Antimicrob Agents Chemother 54:969–976
Campbell IM (1984) Secondary metabolism and microbial physiology. Adv Microb Physiol 25:1–60
Catnach SM, Fairclough PD (1992) Erythromycin and the gut. Gut 33:397–401
Davies J, von Ahsen U, Wank H, Schroeder R (1992) Evolution of secondary metabolite production: potential roles for antibiotics as prebiotic effectors of catalytic RNA reactions. In: Chadwick DJ and Whelan J (eds) Secondary metabolites: their function and evolution. Ciba Foundation symposium:171 Wiley, Chichester, pp 24–32
Davies J, Spiegelman GB, Yim G (2006) The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 9:1–9
Davies J, Ryan KS (2012) Introducing the Parvome: bioactive compounds in the microbial world. ACS Chem Biol; 7:252–9
Demain AL, Sanchez S (2009) Microbial drug discovery: 80 years of progress. J Antibiot (Tokyo) 62:5–16
Firn RD, Jones CG (2003) The origin of secondary metabolism-a unifying model. Mol Microbiol 37:989–994
Fischbach MA, Walsh CT, Clardy J (2008) The evolution of gene collectives: How natural selection drives chemical innovation. In: Proc Natl Acad Sci USA,105:4601–4608
Freestone PP, Sandrini SM, Haigh RD, Lyte M (2008) Microbial endocrinology: how stress influences susceptibility to infection. Trends Microbiol 16:55–64
Kendig EL, Le HH, Belcher SM (2010) Defining hormesis: evaluation of a complex concentration response phenomenon. International J of Toxicol 29:235–246
Miao V, Davies J (2010) Actinobacteria: the good, the bad, and the ugly. Antonie van Leeuwenhoek doi: 10.1007/s10482-010-9440-6
Muller K (2001) Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol 56:9–16
Noller, HF (2012) Evolution of protein synthesis from an RNA world, Cold Spring Harb Perspect Biol, 4: a003681.
Pizzarello S and Shock E (2010) The organic composition of carbonaceous meteorites: the evolutionary story ahead of biochemistry. Cold Spring Harbor Perspect Biol, Mar 2010.
Plotkin BJ, Viselli SM (2000) Effect of insulin on microbial growth. Curr Microbiol 41:60–64
Ridley CP, Lee HY, Khosla C (2008) Evolution of polyketide synthases in bacteria. Proc Natl Acad Sci USA 105:4595–4600
Schreiber SL (2005) Small molecules: the missing link in the central dogma. Nat Chem Biol 1:64–66
Strohl WR (1997) Industrial antibiotics: today and the future. In: Strohl WR (ed) Biotechnology of Antibiotics, 1st edn. Marcel Dekker, New York
Teichman SA, Rison SCG, Thornton JM, Riley M, Gough J, Chothia C (2001) The evolution and structural anatomy of the small molecule metabolic pathways in Escherichia coli. J Mol Biol 311:693–708
van der Gulik P, Massar S, Gilis D, Buhrman H, Rooman M (2009) The first peptides: the evolutionary transition between prebiotic amino acids and early proteins. J Theor Biol 261:531–539
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Davies, J. (2014). The Origin and Evolution of Antibiotics. In: Marinelli, F., Genilloud, O. (eds) Antimicrobials. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39968-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-39968-8_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39967-1
Online ISBN: 978-3-642-39968-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)